University

AECL & CNL Build on Longstanding Relationship With the University of New Brunswick Through Collaborative Research Agreement

Retrieved on: 
Friday, June 9, 2023

CHALK RIVER, Ontario, June 09, 2023 (GLOBE NEWSWIRE) -- Atomic Energy of Canada Limited (AECL), Canada’s nuclear Crown corporation, and Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology laboratory, are pleased to announce that they have signed a Memorandum of Understanding (MOU) with the University of New Brunswick (UNB) to pursue collaborative research opportunities. The MOU shows continued momentum for AECL and CNL in their efforts to develop a partnership network with Canada’s academic community, and builds on what has been an already close relationship with one of the country’s leading universities.

Key Points: 
  • That relationship includes the delivery of research conducted in partnership with UNB’s Centre for Nuclear Energy Research (CNER).
  • Last year, this ongoing collaboration culminated in the signing of a partnership agreement to pursue commercial opportunities in the nuclear power industry.
  • However, CNL also maintains facilities in close proximity to UNB, which includes its National Innovation Centre for Cybersecurity in Fredericton, New Brunswick.
  • To learn more about CNL, including its research projects and programs, please visit www.cnl.ca .

IVÁN CERVANTES CLAIMS GUINNESS WORLD RECORDS TITLE FOR THE GREATEST DISTANCE ON A MOTORCYCLE IN 24 HOURS WITH A TIGER 1200 GT EXPLORER

Retrieved on: 
Friday, June 9, 2023

Nardò, Italy, June 09, 2023 (GLOBE NEWSWIRE) -- Iván Cervantes, 5x Enduro World Champion and Triumph Global Ambassador, has officially claimed the GUINNESS WORLD RECORDS™ title for ‘The greatest distance on a motorcycle in 24 hours (individual)’.

Key Points: 
  • Nardò, Italy, June 09, 2023 (GLOBE NEWSWIRE) -- Iván Cervantes, 5x Enduro World Champion and Triumph Global Ambassador, has officially claimed the GUINNESS WORLD RECORDS™ title for ‘The greatest distance on a motorcycle in 24 hours (individual)’.
  • Iván Cervantes is a 5-time Enduro World Champion, 21-time Spanish Enduro Champion, and 5-time Spanish Motocross Champion.
  • The motorcycle used for the attempt was a Tiger 1200 GT Explorer, chosen at random from the production line at Triumph’s factory in Hinckley, UK.
  • Average speed over 24 hours:         104.26mph / 167.79km/h
    “The Tiger 1200 GT Explorer was the perfect bike for this attempt.

Ottawa OBGYN becomes new president of the SOGC

Retrieved on: 
Friday, June 9, 2023

OTTAWA, June 09, 2023 (GLOBE NEWSWIRE) -- Today, a physician from Ottawa, Dr. Amanda Black became the new president of the Society of Obstetricians and Gynaecologists of Canada (SOGC) at their Annual Clinical Scientific Conference (ACSC 2023).

Key Points: 
  • OTTAWA, June 09, 2023 (GLOBE NEWSWIRE) -- Today, a physician from Ottawa, Dr. Amanda Black became the new president of the Society of Obstetricians and Gynaecologists of Canada (SOGC) at their Annual Clinical Scientific Conference (ACSC 2023).
  • Dr. Black is a Professor of Obstetrics and Gynecology at The University of Ottawa.
  • She holds appointments at The Ottawa Hospital and CHEO and is an Associate Scientist at the Ottawa Hospital Research Institute (OHRI).
  • Dr. Black holds the Dr. Elaine Jolly Chair in Women’s Health Research at The University of Ottawa.

Notable Labs Presents Data Demonstrating PPMP’s Potential to Identify Novel Drug Combinations in JMML at the 2023 EHA Hybrid Congress

Retrieved on: 
Friday, June 9, 2023

FOSTER CITY, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today presented data from an ex vivo study demonstrating the potential for its Predictive Precision Medicine Platform (PPMP) to identify more active investigational pre-hematopoietic stem cell therapy (pre-HCST) regimens for the treatment of juvenile myelomonocytic leukemia (JMML) at the European Hematology Association (EHA) Hybrid Congress being held in Frankfurt, Germany on June 8 – 15, 2023.

Key Points: 
  • Of 130 drug combinations, 27 were shown to be more active in killing leukemic cells ex vivo than compounds represented in these combinations on their own.
  • These results highlight PPMP as a potential tool for identifying superior drug combinations for patients with high medical needs, including with JMML.
  • Abstract title: Tretinoin and calcitriol enhance treatment regimens for juvenile myelomonocytic leukemia in ex vivo drug sensitivity assays.
  • Additional meeting information can be found on the 2023 EHA Congress website, https://ehaweb.org/congress/eha2023-hybrid-congress/eha2023/ .

Jones Soda Co. Announces Appointment of David Knight as New President and Chief Executive Officer

Retrieved on: 
Thursday, June 8, 2023

Mr. Knight has a Bachelor of Business, Marketing from the University of New South Wales in Sydney, Australia.

Key Points: 
  • Mr. Knight has a Bachelor of Business, Marketing from the University of New South Wales in Sydney, Australia.
  • I believe Jones is well-positioned for continued growth and I look forward to building on the momentum that Mark has started,” stated Mr. Knight.
  • Mr. Knight will succeed Mark Murray, who while retiring as the Company‘s President and Chief Executive Officer, will continue to remain on the Board as a director.
  • “On behalf of the full Board, I would like to thank Mark for his tireless service to Jones as President and CEO.

Xtract One Releases Third Quarter Fiscal 2023 Financial Results

Retrieved on: 
Thursday, June 8, 2023

The bookings generated by the Platform operating segment was a 792% increase compared to the same period last year,” stated Peter Evans, Chief Executive Officer of Xtract One.

Key Points: 
  • The bookings generated by the Platform operating segment was a 792% increase compared to the same period last year,” stated Peter Evans, Chief Executive Officer of Xtract One.
  • Loss and comprehensive loss was $13.0 million for the nine month period ended April 30, 2023, compared $8.6 million for the same period in 2022.
  • Xtract One will host a conference call to discuss its annual results on Thursday, June 8, 2023, at 5:30 pm EST.
  • Peter Evans, Xtract One CEO and Director, and Karen Hersh, CFO and Corporate Secretary, will provide an overview of the financial results along with management’s outlook for the business, followed by a question-and-answer period.

AmeriCorps Invests $15.5 Million in Michigan to Improve Education and Health Equity

Retrieved on: 
Thursday, June 8, 2023

This funding will support more than 1,000 AmeriCorps members as they tackle some of the state’s toughest challenges, including disaster services, economic opportunity, education, environmental stewardship, veteran services, education, health and public safety.

Key Points: 
  • This funding will support more than 1,000 AmeriCorps members as they tackle some of the state’s toughest challenges, including disaster services, economic opportunity, education, environmental stewardship, veteran services, education, health and public safety.
  • Michigan Governor Gretchen Whitmer praised AmeriCorps members and AmeriCorps Seniors volunteers tackling some of biggest issues facing Michiganders every day.
  • “Michigan’s hardworking AmeriCorps members are on the ground every day in communities across our state, serving Michiganders and tackling some of the toughest challenges facing Michigan families,” said Michigan Governor Gretchen Whitmer.
  • “AmeriCorps is proud to support more than 20 local organizations across the state of Michigan through a $15.5 million investment to improve education outcomes, increase health access equity, address the climate crisis and boost economic opportunities for Michiganders,” said Michael D. Smith, CEO, AmeriCorps.

James River Announces Retirement of Non-Executive Chairman

Retrieved on: 
Thursday, June 8, 2023

“Serving James River as CEO and Chairman has been an honor," said Mr. Abram.

Key Points: 
  • “Serving James River as CEO and Chairman has been an honor," said Mr. Abram.
  • He has been instrumental to James River’s success throughout his tenure serving as Chief Executive Officer and Chairman.
  • At Towers Watson, Mr. Sherman functioned as a consulting actuary and practice manager for Tower Watson’s property and casualty division for over 25 years.
  • in Applied Mathematics, and he is a Fellow of the Casualty Actuarial Society.

IMUNON’s CEO Presents Business Overview to Investors and Senior Biopharmaceutical Professionals at the BIO 2023 International Convention

Retrieved on: 
Thursday, June 8, 2023

LAWRENCEVILLE, N.J., June 08, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces that President and Chief Executive Officer Dr. Corinne Le Goff presented an overview of IMUNON’s business progress and its progress to an audience of investors and biopharmaceutical professionals at the BIO 2023 International Convention underway in Boston.

Key Points: 
  • Dr.
  • She provided context for the use of DNA in these platforms, updates on the pipeline and clinical trials including the combination trial with Avastin, and an overview of IMUNON’s financial status.
  • Dr.
  • The BIO 2023 convention brought together more than 18,000 delegates from over 60 countries to network, learn and collaborate on the latest trends and innovations in the industry.

Candel Therapeutics Appoints Experienced Manufacturing Leader Nicoletta Loggia, PhD, RPh to its Board of Directors

Retrieved on: 
Thursday, June 8, 2023

“We are pleased to welcome Nicoletta as a new member of Candel’s Board,” said Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer (CEO) of Candel.

Key Points: 
  • “We are pleased to welcome Nicoletta as a new member of Candel’s Board,” said Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer (CEO) of Candel.
  • “Her wealth of strategic and hands-on industry experience in drug development and manufacturing makes her an important addition to our Board as we advance our late-stage oncology programs.
  • She oversaw the integration of the CAR-T teams and AveXis’ AAV technical capabilities into Novartis’ technical research and development.
  • She is also a registered pharmacist and member of the UK Royal and Italian Pharmaceutical societies.